Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
PolyMedica probe: SEC investigation into alleged Medicare over-billing has been terminated, company announces April 8. "No enforcement action has been recommended" by the SEC to the oversight committee that was looking into the alleged fraud (1"The Gray Sheet" Aug. 13, 2001, p. 14), PolyMedica says. "We will continue to cooperate with the Department of Justice with regard to its investigation into the company as well." News of the terminated investigation sent the stock up 53%, to close at $38.90 the day of the announcement...